Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06069609 · ClinicalTrials.gov registry record · NA
Orientation Characteristics of Daily Disposable Toric Contact Lenses
A NA study of Astigmatism, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06069609: Completed NA study of Astigmatism, sponsored by Bausch & Lomb Incorporated.
NCT06069609 is a NA study of Astigmatism that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06069609, a NA study of Astigmatism, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Brief summary: Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double-masked (subject and investigator), repeated measures insertion study.
Primary Outcome
Primary gaze orientation 5 minutes after lens insertion
Conditions Studied
Interventions
- DEVICE kalifilcon A Daily Disposable Toric
- DEVICE Acuvue Oasys 1-Day for Astigmatism
Study Locations (1)
New York
- Bausch & Lomb, Incorporated - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-08-11 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
What the finished NCT06069609 record still lists
NCT06069609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which kalifilcon A Daily Disposable Toric is the first listed.
NCT06069609 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06069609 about?
NCT06069609 is a clinical study titled "Orientation Characteristics of Daily Disposable Toric Contact Lenses". Brief summary: Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double-masked (subject and investigator), repeated measures insertion study.
What is the current status of trial NCT06069609?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-08-11. Estimated completion is 2023-08-15.
What conditions does trial NCT06069609 study?
This clinical trial studies the following conditions: Astigmatism.
What interventions are being tested in trial NCT06069609?
The interventions under investigation include: kalifilcon A Daily Disposable Toric (DEVICE), Acuvue Oasys 1-Day for Astigmatism (DEVICE).
Who is sponsoring clinical trial NCT06069609?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06069609 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06069609's enrollment target sits among peer trials
30 27th of 31 higher than 4 of 31 other Astigmatism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Astigmatism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI